Product References
Myeloid-derived suppressor cells infiltration in non-small-cell lung cancer tumor and MAGE-A4 and NY-ESO-1 expression.
Oncology letters
Hou Z,Liang X,Wang X,Zhou Z,Shi G
35-6200 was used in Immunohistochemistry to investigate the diagnostic and prognostic value of MAGE-A4 and NY-ESO-1 in non-small cell lung cancer.
Mon Jun 01 00:00:00 UTC 2020
Myeloid-derived suppressor cells infiltration in non-small-cell lung cancer tumor and MAGE-A4 and NY-ESO-1 expression.
Oncology letters
Hou Z,Liang X,Wang X,Zhou Z,Shi G
35-6200 was used in Immunohistochemistry to investigate the diagnostic and prognostic value of MAGE-A4 and NY-ESO-1 in non-small cell lung cancer.
Mon Jun 01 00:00:00 UTC 2020
Sublethal Radiation Affects Antigen Processing and Presentation Genes to Enhance Immunogenicity of Cancer Cells.
International journal of molecular sciences
Punnanitinont A,Kannisto ED,Matsuzaki J,Odunsi K,Yendamuri S,Singh AK,Patnaik SK
35-6200 was used in Flow cytometry/Cell sorting to help explain the immunostimulatory role of cancer radiotherapy.
Tue Apr 07 00:00:00 UTC 2020
Sublethal Radiation Affects Antigen Processing and Presentation Genes to Enhance Immunogenicity of Cancer Cells.
International journal of molecular sciences
Punnanitinont A,Kannisto ED,Matsuzaki J,Odunsi K,Yendamuri S,Singh AK,Patnaik SK
35-6200 was used in Flow cytometry/Cell sorting to help explain the immunostimulatory role of cancer radiotherapy.
Tue Apr 07 00:00:00 UTC 2020
Extramammary Paget disease shows differential expression of B7 family members B7-H3, B7-H4, PD-L1, PD-L2 and cancer/testis antigens NY-ESO-1 and MAGE-A.
Oncotarget
Pourmaleki M,Young JH,Socci ND,Chiang S,Edelweiss M,Li Y,Zhang M,Roshal L,Chi DS,Busam KJ,Mellinghoff IK,Hollmann TJ
Published figure using NY-ESO-1 monoclonal antibody (Product # 35-6200) in Immunohistochemistry
Tue Oct 22 00:00:00 UTC 2019
Immune landscape and in vivo immunogenicity of NY-ESO-1 tumor antigen in advanced neuroblastoma patients.
BMC cancer
Camisaschi C,Renne SL,Beretta V,Rini F,Spagnuolo RD,Tuccitto A,Podda MG,Parmiani G,Rivoltini L,Collini P,Castelli C,Luksch R
35-6200 was used in Immunohistochemistry to investigate the immune landscape of neuroblastoma and evaluate the in vivo immunogenicity of the NY-ESO-1 tumour antigen in advanced neuroblastoma patients.
Tue Oct 16 00:00:00 UTC 2018
Expression and immunogenicity of NY-ESO-1 in colorectal cancer.
Experimental and therapeutic medicine
Li Y,Song R,Li X,Xu F
Published figure using NY-ESO-1 monoclonal antibody (Product # 35-6200) in Immunohistochemistry
Thu Jun 01 00:00:00 UTC 2017
T cells targeting NY-ESO-1 demonstrate efficacy against disseminated neuroblastoma.
Oncoimmunology
Singh N,Kulikovskaya I,Barrett DM,Binder-Scholl G,Jakobsen B,Martinez D,Pawel B,June CH,Kalos MD,Grupp SA
Published figure using NY-ESO-1 monoclonal antibody (Product # 35-6200) in Flow Cytometry
Tue Jan 12 00:00:00 UTC 2021
Induction of cancer testis antigen expression in circulating acute myeloid leukemia blasts following hypomethylating agent monotherapy.
Oncotarget
Srivastava P,Paluch BE,Matsuzaki J,James SR,Collamat-Lai G,Blagitko-Dorfs N,Ford LA,Naqash R,Lübbert M,Karpf AR,Nemeth MJ,Griffiths EA
356200 was used in western blot to test if AML patients treated decitabine have induced expression of cancer testis antigens
Tue Mar 15 00:00:00 UTC 2016
NY-ESO-1 (CTAG1B) expression in mesenchymal tumors.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
Endo M,de Graaff MA,Ingram DR,Lim S,Lev DC,Briaire-de Bruijn IH,Somaiah N,Bovée JV,Lazar AJ,Nielsen TO
35-6200 was used in immunohistochemistry - paraffin section to investigate NY-ESO-1 in mesenchymal tumors
Wed Apr 01 00:00:00 UTC 2015
Treatment with 5-Aza-2'-Deoxycytidine Induces Expression of NY-ESO-1 and Facilitates Cytotoxic T Lymphocyte-Mediated Tumor Cell Killing.
PloS one
Klar AS,Gopinadh J,Kleber S,Wadle A,Renner C
35-6200 was used in flow cytometry and western blot to use 5-aza-2'-deoxycytidine to upregulate NY-ESO-1 expression by tumor cells
Fri Jun 10 00:00:00 UTC 2016
Treatment with 5-Aza-2'-Deoxycytidine Induces Expression of NY-ESO-1 and Facilitates Cytotoxic T Lymphocyte-Mediated Tumor Cell Killing.
PloS one
Klar AS,Gopinadh J,Kleber S,Wadle A,Renner C
35-6200 was used in flow cytometry and western blot to use 5-aza-2'-deoxycytidine to upregulate NY-ESO-1 expression by tumor cells
Fri Jun 10 00:00:00 UTC 2016
Induction of antigen-specific immunity with a vaccine targeting NY-ESO-1 to the dendritic cell receptor DEC-205.
Science translational medicine
Dhodapkar MV,Sznol M,Zhao B,Wang D,Carvajal RD,Keohan ML,Chuang E,Sanborn RE,Lutzky J,Powderly J,Kluger H,Tejwani S,Green J,Ramakrishna V,Crocker A,Vitale L,Yellin M,Davis T,Keler T
35-6200 was used in immunohistochemistry to report enhanced anticancer immunity using dendritic cells to present endocytosed material and initiate T cell immunity.
Wed Apr 16 00:00:00 UTC 2014
Immunomodulatory action of SGI-110, a hypomethylating agent, in acute myeloid leukemia cells and xenografts.
Leukemia research
Srivastava P,Paluch BE,Matsuzaki J,James SR,Collamat-Lai G,Karbach J,Nemeth MJ,Taverna P,Karpf AR,Griffiths EA
35-6200 was used in western blot to investigate the effect of SGI-110 on cancer testis antigen gene-regulated expression
Sat Nov 01 00:00:00 UTC 2014
Decitabine facilitates immune recognition of sarcoma cells by upregulating CT antigens, MHC molecules, and ICAM-1.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine
Krishnadas DK,Bao L,Bai F,Chencheri SC,Lucas K
35-6200 was used in western blot to test if demethylating chemotherapy increases the expression of cancer specific antigens.
Sun Jun 01 00:00:00 UTC 2014
Gene expression profiling using nanostring digital RNA counting to identify potential target antigens for melanoma immunotherapy.
Clinical cancer research : an official journal of the American Association for Cancer Research
Beard RE,Abate-Daga D,Rosati SF,Zheng Z,Wunderlich JR,Rosenberg SA,Morgan RA
35-6200 was used in immunohistochemistry to discuss how to select appropriate target antigens for immunotherapy for the treatment of metastatic cancer.
Sun Sep 15 00:00:00 UTC 2013
Gene expression profiling using nanostring digital RNA counting to identify potential target antigens for melanoma immunotherapy.
Clinical cancer research : an official journal of the American Association for Cancer Research
Beard RE,Abate-Daga D,Rosati SF,Zheng Z,Wunderlich JR,Rosenberg SA,Morgan RA
35-6200 was used in immunohistochemistry to discuss how to select appropriate target antigens for immunotherapy for the treatment of metastatic cancer.
Sun Sep 15 00:00:00 UTC 2013
Potential therapeutic value of dendritic cells loaded with NY‑ESO‑1 protein for the immunotherapy of advanced hepatocellular carcinoma.
International journal of molecular medicine
Chen Y,Huang A,Gao M,Yan Y,Zhang W
35-6200 was used in immunohistochemistry (paraffin) to assess the therapeutic value of DCs pulsed with NY ESO 1 to treat hepatocellular carcinoma.
Sun Dec 01 00:00:00 UTC 2013
Expression of MAGE-C1/CT7 and selected cancer/testis antigens in ovarian borderline tumours and primary and recurrent ovarian carcinomas.
Virchows Archiv : an international journal of pathology
Zimmermann AK,Imig J,Klar A,Renner C,Korol D,Fink D,Stadlmann S,Singer G,Knuth A,Moch H,Caduff R
35-6200 was used in immunohistochemistry - paraffin section and western blot to determine the prevalence and biologic relevance of MAGE-C1/CT7 and other antigens using ovarian cancer samples.
Wed May 01 00:00:00 UTC 2013
Effector memory and central memory NY-ESO-1-specific re-directed T cells for treatment of multiple myeloma.
Gene therapy
Schuberth PC,Jakka G,Jensen SM,Wadle A,Gautschi F,Haley D,Haile S,Mischo A,Held G,Thiel M,Tinguely M,Bifulco CB,Fox BA,Renner C,Petrausch U
35-6200 was used in immunohistochemistry (paraffin) to report that re-directed effector- and central memory T cells specifically recognize tumor cells in vitro and in vivo.
Mon Apr 01 00:00:00 UTC 2013
Ex vivo enrichment of circulating anti-tumor T cells from both cutaneous and ocular melanoma patients: clinical implications for adoptive cell transfer therapy.
Cancer immunology, immunotherapy : CII
Mazzarella T,Cambiaghi V,Rizzo N,Pilla L,Parolini D,Orsenigo E,Colucci A,Modorati G,Doglioni C,Parmiani G,Maccalli C
35-6200 was used in flow cytometry to investigate the efficacy of the adoptive cell transfer protocol for melanoma patients.
Wed Aug 01 00:00:00 UTC 2012
NY-ESO-1 expression in hepatocellular carcinoma: A potential new marker for early recurrence after surgery.
Oncology letters
Xu H,Gu N,Liu ZB,Zheng M,Xiong F,Wang SY,Li N,Lu J
35-6200 was used in immunohistochemistry (paraffin) to correlate NY-ESO-1 and the recurrence of hepatocellular carcinoma following surgery.
Sun Jan 01 00:00:00 UTC 2012
NY-ESO-1 expression in hepatocellular carcinoma: A potential new marker for early recurrence after surgery.
Oncology letters
Xu H,Gu N,Liu ZB,Zheng M,Xiong F,Wang SY,Li N,Lu J
35-6200 was used in immunohistochemistry (paraffin) to correlate NY-ESO-1 and the recurrence of hepatocellular carcinoma following surgery.
Sun Jan 01 00:00:00 UTC 2012
MAGE-A1, MAGE-A3, and NY-ESO-1 can be upregulated on neuroblastoma cells to facilitate cytotoxic T lymphocyte-mediated tumor cell killing.
Cancer immunology, immunotherapy : CII
Bao L,Dunham K,Lucas K
35-6200 was used in western blot to study mechanisms to pharmacologically increase expression of cancer antigens on neuroblastoma.
Thu Sep 01 00:00:00 UTC 2011
γ-Radiation promotes immunological recognition of cancer cells through increased expression of cancer-testis antigens in vitro and in vivo.
PloS one
Sharma A,Bode B,Wenger RH,Lehmann K,Sartori AA,Moch H,Knuth A,Boehmer Lv,Broek Mv
35-6200 was used in immunohistochemistry (paraffin) to test if γ-radiation increases expression of cancer-testis antigens and MHC-I, thus promotes efficient immunological control.
Mon Apr 09 00:00:00 UTC 2012
γ-Radiation promotes immunological recognition of cancer cells through increased expression of cancer-testis antigens in vitro and in vivo.
PloS one
Sharma A,Bode B,Wenger RH,Lehmann K,Sartori AA,Moch H,Knuth A,Boehmer Lv,Broek Mv
35-6200 was used in immunohistochemistry (paraffin) to test if γ-radiation increases expression of cancer-testis antigens and MHC-I, thus promotes efficient immunological control.
Mon Apr 09 00:00:00 UTC 2012
γ-Radiation promotes immunological recognition of cancer cells through increased expression of cancer-testis antigens in vitro and in vivo.
PloS one
Sharma A,Bode B,Wenger RH,Lehmann K,Sartori AA,Moch H,Knuth A,Boehmer Lv,Broek Mv
35-6200 was used in immunohistochemistry (paraffin) to test if γ-radiation increases expression of cancer-testis antigens and MHC-I, thus promotes efficient immunological control.
Mon Apr 09 00:00:00 UTC 2012
MAGE-C2/CT10 protein expression is an independent predictor of recurrence in prostate cancer.
PloS one
von Boehmer L,Keller L,Mortezavi A,Provenzano M,Sais G,Hermanns T,Sulser T,Jungbluth AA,Old LJ,Kristiansen G,van den Broek M,Moch H,Knuth A,Wild PJ
35-6200 was used in immunohistochemistry (paraffin) to assess cancer-testis antigen in prostate cancer samples.
Wed Nov 09 00:00:00 UTC 2011
MAGE-C2/CT10 protein expression is an independent predictor of recurrence in prostate cancer.
PloS one
von Boehmer L,Keller L,Mortezavi A,Provenzano M,Sais G,Hermanns T,Sulser T,Jungbluth AA,Old LJ,Kristiansen G,van den Broek M,Moch H,Knuth A,Wild PJ
35-6200 was used in immunohistochemistry (paraffin) to assess cancer-testis antigen in prostate cancer samples.
Wed Nov 09 00:00:00 UTC 2011
Antibody responses to NY-ESO-1 in primary breast cancer identify a subtype target for immunotherapy.
PloS one
Hamaï A,Duperrier-Amouriaux K,Pignon P,Raimbaud I,Memeo L,Colarossi C,Canzonieri V,Perin T,Classe JM,Campone M,Jézéquel P,Campion L,Ayyoub M,Valmori D
35-6200 was used in immunohistochemistry (paraffin) to investigate ESO-based immunotherapy in breast cancer patients.
Fri Nov 04 00:00:00 UTC 2011
Immunobiological characterization of cancer stem cells isolated from glioblastoma patients.
Clinical cancer research : an official journal of the American Association for Cancer Research
Di Tomaso T,Mazzoleni S,Wang E,Sovena G,Clavenna D,Franzin A,Mortini P,Ferrone S,Doglioni C,Marincola FM,Galli R,Parmiani G,Maccalli C
35-6200 was used in flow cytometry to characterize glioblastoma multiforme cancer stem cells
Mon Feb 01 00:00:00 UTC 2010
Fucoidin enhances dendritic cell-mediated T-cell cytotoxicity against NY-ESO-1 expressing human cancer cells.
Biochemical and biophysical research communications
Hu Y,Cheng SC,Chan KT,Ke Y,Xue B,Sin FW,Zeng C,Xie Y
35-6200 was used in flow cytometry to report that fucoidin enhances the cross-presentation of NY-ESO-1 to T cells
Fri Feb 12 00:00:00 UTC 2010
Frequent expression of the novel cancer testis antigen MAGE-C2/CT-10 in hepatocellular carcinoma.
International journal of cancer
Riener MO,Wild PJ,Soll C,Knuth A,Jin B,Jungbluth A,Hellerbrand C,Clavien PA,Moch H,Jochum W
35-6200 was used in immunohistochemistry - paraffin section to ascertain the expression of several cancer testis antigens in hepatocellular carcinomas, intrahepatic cholangiocarcinomas, extrahepatic cholangiocarcinomas, and gallbladder carcinomas
Thu Jan 15 00:00:00 UTC 2009
Modified tumour antigen-encoding mRNA facilitates the analysis of naturally occurring and vaccine-induced CD4 and CD8 T cells in cancer patients.
Cancer immunology, immunotherapy : CII
Knights AJ,Nuber N,Thomson CW,de la Rosa O,Jäger E,Tiercy JM,van den Broek M,Pascolo S,Knuth A,Zippelius A
35-6200 was used in flow cytometry to determine the applicability of a modified, in vitro-transcribed mRNA that encodes a therapeutically relevant tumor antigen to analyze T cell responses in cancer patients
Sun Mar 01 00:00:00 UTC 2009
p53 autoantibodies, cytokine levels and ovarian carcinogenesis.
Gynecologic oncology
Tsai-Turton M,Santillan A,Lu D,Bristow RE,Chan KC,Shih IeM,Roden RB
35-6200 was used in ELISA to test if type II ovarian carcinoma, mutation of p53, and plasma levels of particular cytokines are associated with the generation of p53-specific serum autoantibody responses in patients
Wed Jul 01 00:00:00 UTC 2009
MAGE-C1/CT-7 expression in plasma cell myeloma: sub-cellular localization impacts on clinical outcome.
Cancer science
Tinguely M,Jenni B,Knights A,Lopes B,Korol D,Rousson V,Curioni Fontecedro A,Cogliatti SB,Bittermann AG,Schmid U,Dommann-Scherrer C,Maurer R,Renner C,Probst-Hensch NM,Moch H,Knuth A,Zippelius A
35-6200 was used in immunocytochemistry and immunohistochemistry - paraffin section to examine the expression of several cancer-testis antigens in patients with monoclonal gammopathy of undetermined significance
Tue Apr 01 00:00:00 UTC 2008
Tumor-infiltrating T cells correlate with NY-ESO-1-specific autoantibodies in ovarian cancer.
PloS one
Milne K,Barnes RO,Girardin A,Mawer MA,Nesslinger NJ,Ng A,Nielsen JS,Sahota R,Tran E,Webb JR,Wong MQ,Wick DA,Wray A,McMurtrie E,Köbel M,Kalloger SE,Gilks CB,Watson PH,Nelson BH
35-6200 was used in immunohistochemistry to study autoantibodies and tumor-infiltrating T cells in epithelial ovarian cancer
Thu Dec 18 00:00:00 UTC 2008
NY-ESO-1 protein expression in primary breast carcinoma and metastases: correlation with CD8+ T-cell and CD79a+ plasmacytic/B-cell infiltration.
International journal of cancer
Theurillat JP,Ingold F,Frei C,Zippelius A,Varga Z,Seifert B,Chen YT,Jäger D,Knuth A,Moch H
35-6200 was used in immunohistochemistry - paraffin section to examine NY-ESO-1 expression in various types of breast cancer
Fri Jun 01 00:00:00 UTC 2007
Cancer-germline gene expression in pediatric solid tumors using quantitative real-time PCR.
International journal of cancer
Jacobs JF,Brasseur F,Hulsbergen-van de Kaa CA,van de Rakt MW,Figdor CG,Adema GJ,Hoogerbrugge PM,Coulie PG,de Vries IJ
35-6200 was used in immunohistochemistry - paraffin section to identify and evaluate cancer-germline genes for therapeutic vaccine targets in various pediatric solid tumors
Mon Jan 01 00:00:00 UTC 2007
Oral premalignant lesions induce immune reactivity to both premalignant oral lesions and head and neck squamous cell carcinoma.
Cancer immunology, immunotherapy : CII
Young MR,Neville BW,Chi AC,Lathers DM,Boyd Gillespie M,Day TA
35-6200 was used in immunohistochemistry - paraffin section to study premalignant lesions for markers of head and neck squamous cell carcinoma
Sun Jul 01 00:00:00 UTC 2007
MAD-CT-2 identified as a novel melanoma cancer-testis antigen using phage immunoblot analysis.
Journal of immunotherapy (Hagerstown, Md. : 1997)
Dubovsky JA,Albertini MR,McNeel DG
35-6200 was used in western blot to identify MAD-CT-2 as a novel melanoma cancer-testis antigens
Mon Oct 01 00:00:00 UTC 2007
Restriction of GAGE protein expression to subpopulations of cancer cells is independent of genotype and may limit the use of GAGE proteins as targets for cancer immunotherapy.
British journal of cancer
Gjerstorff MF,Johansen LE,Nielsen O,Kock K,Ditzel HJ
35-6200 was used in immunohistochemistry - paraffin section to study the therapeutic target potential of GAGE protein in cancers
Mon Jun 19 00:00:00 UTC 2006
Tumor infiltrating lymphocytes in seminoma lesions comprise clonally expanded cytotoxic T cells.
International journal of cancer
Hadrup SR,Braendstrup O,Jacobsen GK,Mortensen S,Pedersen LØ,Seremet T,Andersen MH,Becker JC,Straten PT
35-6200 was used in immunohistochemistry - paraffin section to characterize tumor infiltrating lymphocytes from seminoma lesions
Tue Aug 15 00:00:00 UTC 2006
Heterogeneous expression of GAGE, NY-ESO-1, MAGE-A and SSX proteins in esophageal cancer: Implications for immunotherapy.
International journal of cancer
Akcakanat A,Kanda T,Tanabe T,Komukai S,Yajima K,Nakagawa S,Ohashi M,Hatakeyama K
Sun Jan 01 00:00:00 UTC 2006
Quantifying and imaging NY-ESO-1/LAGE-1-derived epitopes on tumor cells using high affinity T cell receptors.
Journal of immunology (Baltimore, Md. : 1950)
Purbhoo MA,Sutton DH,Brewer JE,Mullings RE,Hill ME,Mahon TM,Karbach J,Jäger E,Cameron BJ,Lissin N,Vyas P,Chen JL,Cerundolo V,Jakobsen BK
35-6200 was used in flow cytometry to visualize HLA-peptide presentation for the first time
Thu Jun 15 00:00:00 UTC 2006
Expression profile of cancer-testis genes in 121 human colorectal cancer tissue and adjacent normal tissue.
Clinical cancer research : an official journal of the American Association for Cancer Research
Li M,Yuan YH,Han Y,Liu YX,Yan L,Wang Y,Gu J
35-6200 was used in immunohistochemistry - paraffin section to examine the expression of cancer-testis antigen genes and correlate their expression with pathologic characteristics colorectal cancer patients
Tue Mar 01 00:00:00 UTC 2005
